当前位置:首页 > 股票大全 > 药明康德 603259 财务分析

药明康德财务分析

整理编辑:168股票行情网www.gphq168.com    数据来源:互联网 经供参考

药明康德(603259)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入7,981,934,236.9640,340,806,877.0429,541,326,133.5818,871,285,497.62
营业总成本5,643,908,863.6428,708,590,806.3820,390,754,912.9413,155,192,160.22
营业利润2,309,847,178.7611,872,285,906.479,807,416,477.556,412,440,472.19
利润总额2,297,394,139.811,831,990,991.159,781,966,276.666,395,212,941.23
净利润1,958,853,204.959,700,260,033.278,148,647,084.335,356,896,235.84
其他综合收益-213,721,368.5286,920,855.5-543,935,758.12-513,668,492.23
综合收益总额1,745,131,836.439,787,180,888.777,604,711,326.214,843,227,743.61
药明康德(603259)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计31,153,381,549.1930,422,470,960.8229,777,189,611.6627,580,065,949.01
非流动资产合计43,786,466,187.3843,246,878,346.341,982,091,626.2741,739,067,781.67
资产总计74,939,847,736.5773,669,349,307.1271,759,281,237.9369,319,133,730.68
流动负债合计13,387,432,882.5414,756,296,165.5716,979,131,571.4616,363,159,319.29
非流动负债合计5,504,117,842.473,395,607,728.812,791,747,274.142,757,192,800.13
负债合计18,891,550,725.0118,151,903,894.3819,770,878,845.619,120,352,119.42
归属于母公司股东权益合计55,639,487,743.3455,122,453,910.7351,586,653,307.0149,825,285,290.99
股东权益合计56,048,297,011.5655,517,445,412.7451,988,402,392.3350,198,781,611.26
负债和股东权益合计74,939,847,736.5773,669,349,307.1271,759,281,237.9369,319,133,730.68
药明康德(603259)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计10,421,436,141.2342,272,825,974.731,562,847,90120,308,833,471.6
经营活动现金流出小计8,164,318,333.3728,885,914,195.9321,246,060,041.4314,710,652,737.45
经营活动产生的现金流量净额2,257,117,807.8613,386,911,778.7710,316,787,859.575,598,180,734.15
投资活动现金流入小计2,189,367,1362,899,446,215.911,557,031,673.361,151,810,129.58
投资活动现金流出小计3,043,749,990.6210,459,979,779.627,338,996,949.662,713,917,920.76
投资活动产生的现金流量净额-854,382,854.62-7,560,533,563.71-5,781,965,276.3-1,562,107,791.18
筹资活动现金流入小计2,929,323,063.977,090,611,257.546,220,542,405.154,831,581,352.73
筹资活动现金流出小计2,972,618,043.2111,031,994,942.279,524,529,824.837,447,523,962.28
筹资活动产生的现金流量净额-43,294,979.24-3,941,383,684.73-3,303,987,419.68-2,615,942,609.55
汇率变动对现金及现金等价物的影响156,482,470.23132,139,998.6231,612,284.73181,005,246.33
现金及现金等价物净增加额1,515,922,444.232,017,134,528.931,462,447,448.321,601,135,579.75
期末现金及现金等价物余额11,516,961,256.2510,001,038,812.029,446,351,731.419,585,039,862.84
药明康德603259相关数据
今日股市大盘指数